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An outbreak of viral encephalitis occurred in northern 
India in 2006. Attempts to identify an etiologic agent in cere-
brospinal ﬂ  uid by using reverse transcription–PCR showed 
positivity to enterovirus (EV) in 66 (21.6%) of 306 patients. 
Sequencing and phylogenetic analyses of PCR products 
from 59 (89.3%) of 66 specimens showed similarity with 
EV-89 and EV-76 sequences.
A
cute viral encephalitis is caused by a wide range of 
viruses and can occur either in sporadic episodes or in 
outbreaks. Viral etiologic agents that have been identiﬁ  ed 
as causing encephalitis include herpesvirus, enterovirus, 
alphavirus, inﬂ  uenza A virus, rabies virus, HIV, ﬂ  avivirus, 
and Chandipura (CHP) virus (1,2). An outbreak of viral en-
cephalitis was reported from April through October 2006 
from predominantly Gorakhpur and 5 adjoining districts 
of eastern Uttar Pradesh (Maharajganj, Kushinagar, Sant 
Kabir Nagar, Siddharthnagar, and Deoria) and 2 adjoining 
districts of Bihar (Gopalganj and West Champaran), loca-
tions where Japanese encephalitis (JE) is known to be en-
demic in India. According to state government health ser-
vices records, 1,912 cases of viral encephalitis occurred in 
these areas, and 411 (21.5%) patients died. From August 
through September 2006, we investigated 306 patients ad-
mitted with encephalitis to Baba Raghav Das Medical Col-
lege in Gorakhpur, Uttar Pradesh. The patients represented 
all 8 districts of eastern Uttar Pradesh. ELISA and reverse 
transcription–PCR (RT-PCR) performed on the patients’ 
cerebrospinal ﬂ  uid (CSF) samples identiﬁ  ed 40 (13.1%) of 
306 specimens as positive for JE virus (3). Laboratory tests 
were negative for alphavirus and CHP virus, and the etio-
logic agent in a large number of cases was unidentiﬁ  ed.
Enteroviruses (EVs) cause a wide variety of diseases 
that range from nonspeciﬁ  c viral illness to mild infections 
of herpangina and hand, foot, and mouth disease to poten-
tially serious diseases such as myopericarditis, meningitis, 
myelitis, and neonatal sepsis. EVs are also etiologic agents 
of encephalitis outbreaks in humans (4). These viruses com-
prise more than 90 serotypes, and most are known to cause 
human infections. We focused on the detection, isolation, 
and molecular characterization of EVs in 306 patients from 
eastern Uttar Pradesh.
The Study
A total of 850 specimens collected from 306 patients 
who had encephalitis included 306 CSF specimens, 304 
blood samples, 120 throat swabs, and 120 rectal swabs. 
All samples were stored at –20oC before being transported 
for analysis and thereafter were stored at –70oC at the Na-
tional Institute of Virology in Pune, India. Laboratory tests 
conducted by state government health services of Uttar 
Pradesh were negative for bacteria and malaria. According 
to standard protocol (2), virus isolation was attempted in 
human rhabdosarcoma (RD) and in baby hamster kidney 
(BHK) cell lines.
Separate aliquots were processed in 2 laboratories to 
maintain quality control and monitor possible contamina-
tion during PCR processing. Viral nucleic acids were ex-
tracted by using viral RNA mini kits (QIAamp, Qiagen, 
Hilden, Germany). RT-PCR was performed for EV by us-
ing 5′ noncoding region (NCR)–speciﬁ  c primers, as has 
been described (5,6). Genotyping was conducted by using 
RT-PCR of virion protein (VP) 1/2A and VP1 regions and 
sequencing (7,8). Table 1 describes the locations and se-
quences of the primers used in the assays.
PCR products were puriﬁ  ed by using a Gel Extraction 
Kit (QIAquick, Qiagen). Both strands were sequenced by 
using BigDye Terminator Cycle Sequencing Ready Reac-
tion Kit (Applied Biosystems, Carlsbad, CA, USA) in ABI 
PRISM 3130 XL Genetic Analyser (Applied Biosystems). 
MEGA 3.1 software generated the phylogenetic tree by us-
ing the neighbor-joining algorithm and Kimura 2–parame-
ter distance model and applying a bootstrap test that used 
1,000 bootstrap replications (9).
Patient age ranged from <1 month to 15 years. Clini-
cal histories available for 253 of the 306 patients showed 
fever and altered sensorium in 100.0%, hepatomegaly in 70 
(27.8%), splenomegaly in 49 (19.4%), and meningeal signs 
in 35 (13.9%) of the 253 patients. 
Specimens available in sufﬁ  cient quantity were inoc-
ulated into RD and BHK cell lines. Specimens that were 
adequate for isolation included 85 of 306 CSF specimens, 
18 of 304 serum samples, 19 of 120 rectal swabs, and 19 
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DOI: 10.3201/eid1502.080865of 120 throat swabs. Cytopathic effect was observed in cell 
cultures inoculated with 4 CSF specimens, 2 rectal swabs, 2 
throat swabs, and 1 serum sample. Electron microscopic ex-
amination of cultures infected with 2 CSF samples showed 
picornavirus-like particles 25–27 nm in diameter. Attempts 
to detect EV RNA in the isolates and clinical specimens 
used nested RT-PCR in 5′ NCR. Eight of 9 cultures showed 
amplicons of 407 bp. Sequences of amplicons from 3 CSF 
specimens and 2 rectal swabs showed 97.2%–98.9% ho-
mology with EV-89 (i.e., the strain named BANoo-10359, 
GenBank accession no. AY697459) and 95.7%–96.9% 
homology with EV-76 (FRA91-10369, GenBank acces-
sion no. AY697458). Sequences from 1 isolate from a CSF 
specimen and 1 isolate from a rectal swab showed 100.0% 
homology with coxsackie virus B3 (CV-B3) strain 20. One 
isolate from serum showed 98.3% homology with coxsack-
ie virus B1 (CV-B1) strain SAMP2.17.
Sixty-six (21.5%) of 306 CSF specimens, 7 (6.4%) 
of 110 rectal swabs, 4 (3.7%) of 110 throat swabs, and 1 
(5.5%) of 18 serum samples showed ampliﬁ  cation in 5′ 
NCR of the EV genome. Sequences of 64 of 78 (82.1%) 
PCR products (59 from CSF specimens, 4 from rectal 
swabs, and 1 from a throat swab) showed 97.2%–98.9% 
and 95.7%–96.9% homology with EV-89 and EV-76, re-
spectively. Ten (12.8%) products (7 from CSF, 2 from 
rectal swabs, and 1 from serum) showed 99.3%–100.0% 
homology with CV-B3 (Figure 1). Three PCR products, 
each derived from a throat swab, showed 93.3%–96.6% 
homology with coxsackie virus A (CV-A), echovirus 11, 
and echovirus 30, respectively. PCR products from a rec-
tal swab showed 96.3% homology with CV-B1. Multiple 
specimen positivity was noted in 6 patients who tested 
positive for EV RNA.
Isolates from 2 of 5 cell cultures, 2 of 59 CSF speci-
mens, and 1 of 4 rectal swabs contained EV-76. Two of 4 
rectal swabs were characterized as EV-89 on the basis of 
partial VP1/2A (2917–3374) or VP1 (2602–2977) gene se-
quences. Phylogenetic analysis revealed 92.7%–97.7% ho-
mology with Bangladesh EV-76 strains (GenBank acces-
sion nos. AY697463, AY697464, AY697471, AY697469, 
AY697462, and AY697468) and 93.6%–94.5% homology 
with EV-89 strain (GenBank accession no. AY697459) 
(Figure 2). Within EV-76 and EV-89 strains of the study, 
homology ranged from 81.2% to 91.3%. Attempts to am-
plify VP1/2A or VP1 regions of EV RNA detected in most 
clinical specimens failed despite the use of sensitive primer 
pairs that have been discussed recently (10).
Table 2 describes details of clinical ﬁ  ndings in the 
subsets of EV-positive and EV-negative specimens of the 
patients for whom clinical histories were available. Further, 
hepatomegaly and splenomegaly appeared to be propor-
tionately higher in patients with enteroviral infections than 
in patients whose specimens were negative for EV and JE 
virus.
Conclusions
The viral RNA detected in CSF samples from patients 
hospitalized with encephalitis in Uttar Pradesh showed 
close identity with the EV-89 and EV-76 that recently 
were reported as an unusual group classiﬁ  ed genetically as 
group A EV (EV-A) (10). Presence of the virus was also 
conﬁ  rmed by its isolation and typing. Human EV-76 was 
detected in isolates in 1 rectal swab and 2 CSF specimens, 
and human EV-89 was detected in 2 rectal swabs by using 
ampliﬁ  cation of VP1/2A or VP1 regions. Sequence analy-
sis showed nt homology of 92.7%–97.7% with Bangladesh 
EV-76 and EV-89 strains recovered from patients with 
acute ﬂ  accid paralysis (AFP). The failure of ampliﬁ  cation 
of typing regions in most specimens may be due to a low 
viral load.
EVs are known to cause severe neurologic diseases 
ranging from AFP to encephalitis (11). In recent years, 
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Table 1. Primers used for PCR and sequencing for enterovirus isolates from encephalitis patients, Uttar Pradesh, India, 2006* 
Serial no.  Region  Location  Primer sequence (5ƍ ĺ 3ƍ)  Product size, bp 
1 5’  NCR  64–84  CGGTACCTTTGTACGCCTGT  537 
2 5’  NCR 601–582  ATTGTCACCATAAGCAGCCA  537 
3 5’  NCR 166–186  CAAGCACTTCTGTTTCCCCGG  400 
4 5’  NCR 566–546  GAAACACGGACACCCAAAGTA  400 
5 VP1/2A  EV-012  (2917–2936)  ATGTAYGTICCICCIGGIGG  457 
6 VP1/2A  EV-040  (2917–2936)  ATGTAYRTICCIMCIGGIGC  457 
7 VP1/2A  EV-011  (3374–3355)  GCICCIGAYTGITGICCRAA  457 
8  VP1 cDNA  AN32 (3009–3002)  GTYTGCCA  NA 
9  VP1 cDNA  AN33 (3009–3002)  GAYTGCCA  NA 
10  VP1 cDNA  AN34 (3111–3104)  CCRTCRTA  NA 
11  VP1 cDNA  AN35 (3009–3002)  RCTYTGCCA  NA 
12 VP3  224(1977–1996)  GCIATGYTIGGIACICAYRT  762 
13 VP1  222  (2969–2951)  CICCIGGIGGIAYRWACAT  762 
14 VP1  AN89  (2602–2627)  CCAGCACTGACAGCAGYNGARAYNGG  348–393 
15 VP1  AN88  (2977–2951)  TACTGGACCACCTGGNGGNAYRWACAT  348–393 
*NCR, noncoding region of viral genome; VP, virion protein; NA, not applicable. Enteroviruses in Patients with Encephalitis, India
Southeast Asian countries have reported outbreaks of en-
cephalitis caused by EV-71 (12,13). During AFP surveil-
lance activities, Bangladesh strains were isolated from 
stool specimens (14). AFP patients infected with echovi-
ruses and coxsackie B viruses also have been detected in 
India (15). Isolation of EV from clinical specimens col-
lected from children with encephalitis in the present study 
indicates viable virus. Detection of EV-89/76 RNA in the 
CSF of ≈20% of the patients suggests the association of 
these viruses with encephalitis. Also, in 10 (3.3%) of 306 
patients, co-infections of JE virus and EV were detected. 
Further studies are needed to understand the relative con-
tributions of these viruses in causing sporadic and outbreak 
infections of encephalitis.
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Figure 1. Phylogenetic tree based on partial 5’ noncoding region 
sequences of enterovirus (EV) genome detected in cerebrospinal 
ﬂ  uid samples from encephalitis patients. Specimens are identiﬁ  ed 
by repository serial numbers obtained from the National Institute of 
Virology (NIV), Pune, India. GenBank accession nos. EU672893–
EU762967 indicate the nucleotide sequences of EV strains of the 
present study. Scale bar indicates nucleotide substitutions per site. 
EV, enterovirus; CSF, cerebrospinal ﬂ  uid; CV-A, coxsackie virus A; 
CV-B, coxsackie virus B; HEV, human enterovirus. 
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Figure 2. Phylogenetic tree based on partial virion protein 1 (VP1) 
sequences (2602–2977) detected in enterovirus (EV) isolates and 
clinical specimens from encephalitis patients. GenBank accession 
nos. indicate the nucleotide sequences of EV strains of the present 
study. Scale bar indicates nucleotide substitutions per site. EV, 
enterovirus; CV-A, coxsackie virus A; CV-B, coxsackie virus B; 
HEV, human enterovirus; NIV, National Institute of Virology, Pune, 
India.Accumulation of water in a saucer-shaped landscape 
(terai) and extensive rice cultivation in eastern Uttar 
Pradesh and adjoining regions favor the growth of vector 
mosquito populations and waterborne pathogens. Though 
the source of infection in the present study is unclear, the 
data warrant active surveillance of encephalitis cases. Inad-
equate hygiene and the unsanitary conditions that prevail 
in the study region may encourage the spread of EV infec-
tions in the community. Studies conducted on environmen-
tal samples may provide clues related to the dynamics of 
EV infections in humans.
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Table 2. Clinical features of encephalitis patients with and without 
EV infections, Upper Pradesh, India, 2006* 
Feature
No. (%) EV 
positive
No. (%) EV 
negative
Fever 51 (100.0)  202 (100.0) 
Altered sensorium  51 (100.0)  202 (100.0) 
Hepatomegaly  13 (25.49)  21 (10.3) 
Splenomegaly  13 (25.49)  32 (15.8) 
Brisk DTR  4 (8.51)†  21 (10.3) 
Meningeal signs  6 (11.7)  20 (9.9) 
Total no. of patients  51 202
*EV, enterovirus; DTR, deep tendon reflex. 
†Denominator is 47 because these data were unavailable for 4 patients.  
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